VOYAGER THERAPEUTICS INC

Voyager Therapeutics plummets 35% as investors question its gene‑therapy pipeline, liquidity, and future prospects—find out why this biotech may be on a steep slide.

Voyager Therapeutics shares drop 35.7% last month, hitting $1.86. Learn how the gene‑therapy firm’s current price, market cap and 52‑week range compare.